Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlled therapeutic trials in polymorphic light eruption.

M F Corbett, J L Hawk, A Herxheimer

    The British Journal of Dermatology
    |November 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Porphyria and Photosensitivity.

    Indian journal of dermatology and venereology·2017
    Same author

    Actinic Reticuloid.

    Indian journal of dermatology and venereology·2017
    Same author

    Chronic actinic dermatitis is not a viable concept-Reply

    Archives of dermatology·2014
    Same author

    Teaching practical prescribing and therapeutics.

    Medical teacher·2014
    Same author

    Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator® ) withdrawal in France.

    Journal of clinical pharmacy and therapeutics·2013
    Same author

    Side effects: freedom of information and the communication of doubt.

    The International journal of risk & safety in medicine·2013
    Same journal

    Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

    The British journal of dermatology·2026
    Same journal

    Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

    The British journal of dermatology·2026
    Same journal

    Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

    The British journal of dermatology·2026
    Same journal

    Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.

    The British journal of dermatology·2026
    Same journal

    Improving Prognostication for Cutaneous Squamous Cell Carcinoma.

    The British journal of dermatology·2026
    Same journal

    Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.

    The British journal of dermatology·2026
    See all related articles

    Treatments for polymorphic light eruption (PLE) like beta-carotene and chloroquine showed minimal effectiveness. Further research is needed to find better therapies for this UVR-induced skin condition.

    Area of Science:

    • Photodermatology
    • Dermatology
    • Clinical Trials

    Background:

    • Polymorphic light eruption (PLE) is a common photodermatosis.
    • Understanding effective treatments for PLE is crucial for patient management.

    Purpose of the Study:

    • To evaluate the efficacy of oral beta-carotene, ketoprofen, chloroquine, and topical benzimidazole sunscreen in treating PLE.
    • To assess the relationship between UVR exposure and PLE symptom severity.

    Main Methods:

    • Controlled clinical trials involving patients with PLE.
    • Patient-recorded symptom data via diary cards.
    • Individual UVR exposure measurement using film badges.

    Main Results:

    • None of the tested treatments were highly effective for PLE.

    Related Experiment Videos

  • Beta-carotene offered slight protection against irritation and erythema, but this was not consistently observed.
  • Chloroquine showed a minor protective effect against irritation.

    • Conclusions:

    • Current treatments for PLE, including beta-carotene and chloroquine, provide limited benefit.
    • The risk-benefit profile of chloroquine for PLE requires careful consideration.
    • Further investigation into alternative treatment strategies and dosages for PLE is warranted.